Enovix (NASDAQ:ENVX – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.03, Briefing.com reports. The company had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. Enovix had a negative return on equity of 96.23% and a negative net margin of 1,180.21%. During the same period in the prior year, the company earned ($0.27) earnings per share. Enovix updated its Q4 guidance to ($0.21)-($0.15) EPS and its Q4 2024 guidance to -0.210–0.150 EPS.
Enovix Price Performance
Shares of ENVX stock traded up $0.14 during mid-day trading on Friday, hitting $9.15. 4,739,153 shares of the stock traded hands, compared to its average volume of 5,619,907. Enovix has a twelve month low of $5.70 and a twelve month high of $18.68. The company has a debt-to-equity ratio of 0.97, a quick ratio of 3.84 and a current ratio of 3.98. The company’s 50-day simple moving average is $10.06 and its 200-day simple moving average is $11.05. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of -5.84 and a beta of 1.98.
Analyst Ratings Changes
ENVX has been the topic of several analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $19.00 target price (down from $23.00) on shares of Enovix in a research report on Monday, August 5th. Benchmark reiterated a “buy” rating and issued a $25.00 price objective on shares of Enovix in a research report on Wednesday. Canaccord Genuity Group boosted their target price on shares of Enovix from $17.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. cut their price target on Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Finally, Oppenheimer reissued an “outperform” rating and issued a $36.00 price objective on shares of Enovix in a report on Monday, August 26th. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Enovix currently has a consensus rating of “Moderate Buy” and an average target price of $20.50.
Insider Activity
In related news, insider Arthi Chakravarthy sold 35,000 shares of Enovix stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $13.00, for a total transaction of $455,000.00. Following the transaction, the insider now directly owns 343,305 shares of the company’s stock, valued at $4,462,965. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 15.70% of the company’s stock.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Stories
- Five stocks we like better than Enovix
- Upcoming IPO Stock Lockup Period, Explained
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- What is an Earnings Surprise?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.